Fig. 10From: Prospective pathway signaling and prognostic values of MicroRNA-9 in ovarian cancer based on gene expression omnibus (GEO): a bioinformatics analysisAssociation between the expressions of FBN1, PRRX1, SMC2, SMC4, and VCAN and the prognosis of patients with ovarian cancer. According to the median expression level, patients with ovarian cancer were divided into high expression group and low expression group. HR:hazard ratioBack to article page